GSA Capital Partners’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.8M Buy
39,259
+24,906
+174% +$2.55M 0.24% 35
2025
Q4
$1.52M Buy
14,353
+6,676
+87% +$774K 0.13% 169
2025
Q3
$975K Sell
7,677
-2,923
-28% -$348K 0.08% 419
2025
Q2
$1.3M Buy
10,600
+5,031
+90% +$575K 0.09% 308
2025
Q1
$564K Sell
5,569
-392
-7% -$38.3K 0.05% 713
2024
Q4
$550K Buy
5,961
+2,436
+69% +$239K 0.04% 811
2024
Q3
$341K Sell
3,525
-5,703
-62% -$512K 0.03% 1160
2024
Q2
$792K Buy
9,228
+5,211
+130% +$437K 0.06% 670
2024
Q1
$332K Sell
4,017
-6,397
-61% -$468K 0.03% 1152
2023
Q4
$695K Sell
10,414
-9,298
-47% -$602K 0.06% 596
2023
Q3
$1.32M Buy
+19,712
New +$1.36M 0.11% 277
2023
Q1
Sell
-3,399
Closed -$203K 1576
2022
Q4
$203K Buy
+3,399
New +$185K 0.03% 1175
2022
Q1
Sell
-16,317
Closed -$847K 1518
2021
Q4
$847K Buy
16,317
+4,225
+35% +$218K 0.11% 287
2021
Q3
$722K Buy
12,092
+7,044
+140% +$443K 0.07% 478
2021
Q2
$313K Buy
+5,048
New +$336K 0.04% 918
2021
Q1
Sell
-6,176
Closed -$406K 1205
2020
Q4
$406K Sell
6,176
-150
-2% -$8.82K 0.07% 558
2020
Q3
$327K Buy
+6,326
New +$325K 0.05% 673
2020
Q2
Sell
-5,277
Closed -$269K 731
2020
Q1
$269K Buy
+5,277
New +$304K 0.07% 549
2019
Q3
Sell
-34,924
Closed -$1.76M 1473
2019
Q2
$1.76M Sell
34,924
-20,346
-37% -$988K 0.2% 66
2019
Q1
$2.57M Buy
55,270
+25,414
+85% +$1.29M 0.26% 40
2018
Q4
$1.47M Sell
29,856
-49,448
-62% -$2.81M 0.17% 109
2018
Q3
$4.92M Buy
79,304
+74,111
+1,427% +$4.51M 0.27% 12
2018
Q2
$280K Buy
+5,193
New +$260K 0.01% 1407
2018
Q1
Sell
-60,640
Closed -$2.38M 1650
2017
Q4
$2.38M Buy
+60,640
New +$2.31M 0.15% 169
2017
Q3
Sell
-29,465
Closed -$1.14M 1678
2017
Q2
$1.14M Buy
+29,465
New +$1.08M 0.07% 467
2017
Q1
Sell
-15,785
Closed -$518K 1798
2016
Q4
$518K Sell
15,785
-22,923
-59% -$744K 0.03% 968
2016
Q3
$1.25M Sell
38,708
-19,617
-34% -$636K 0.07% 478
2016
Q2
$1.8M Buy
58,325
+26,693
+84% +$835K 0.1% 287
2016
Q1
$947K Sell
31,632
-4,318
-12% -$119K 0.06% 580
2015
Q4
$996K Buy
35,950
+440
+1% +$12.5K 0.05% 710
2015
Q3
$1.08M Sell
35,510
-18,164
-34% -$632K 0.05% 578
2015
Q2
$1.97M Buy
53,674
+6,851
+15% +$244K 0.08% 387
2015
Q1
$1.65M Sell
46,823
-10,140
-18% -$347K 0.07% 467
2014
Q4
$1.74M Buy
56,963
+21,313
+60% +$665K 0.12% 184
2014
Q3
$1.05M Sell
35,650
-24,044
-40% -$733K 0.06% 449
2014
Q2
$1.7M Buy
59,694
+47,115
+375% +$1.31M 0.08% 347
2014
Q1
$360K Sell
12,579
-65,366
-84% -$1.7M 0.03% 993
2013
Q4
$2.07M Buy
77,945
+63,591
+443% +$1.77M 0.16% 89
2013
Q3
$394K Sell
14,354
-13,345
-48% -$343K 0.03% 946
2013
Q2
$635K Buy
+27,699
New +$626K 0.08% 420

Other funds holding EHC

GSA Capital Partners's EHC Position: Q1 2026 in Review

GSA Capital Partners increased its Encompass Health (EHC) stake by 174% in Q1 2026, buying an estimated $2.55M and bringing the position to 39,259 shares worth $3.8M. The position accounts for 0.24% of the portfolio, ranked #35.

GSA Capital Partners first reported a position in EHC in Q2 2013 and has held it in 40 quarters since. The position peaked at $4.92M in Q3 2018. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • GSA Capital Partners held 39,259 shares of Encompass Health worth $3.8M as of Q1 2026.
  • GSA Capital Partners bought 24,906 Encompass Health shares in Q1 2026, an estimated $2.55M.
  • Encompass Health made up 0.24% of GSA Capital Partners's portfolio in Q1 2026, its #35 holding.
  • GSA Capital Partners first reported a position in Encompass Health in Q2 2013 and has held it in 40 quarters since.
  • GSA Capital Partners's Encompass Health position peaked at $4.92M in Q3 2018.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.